The effects of supplementation with docosahexaenoic acid (DHA) on DHA level
s in serum, seminal plasma, and sperm of asthenozoospermic men as well as o
n sperm motility were examined in a randomized, double-blind, placebo-contr
olled manner. Asthenozoospermic men (n = 28; less than or equal to 50% moti
lity) were supplemented with 0, 400, or 800 mg DHA/d for 3 mon. Sperm motil
ity and the fatty acid composition of serum, seminal plasma, and sperm phos
pholipid were determined before and after supplementation. In serum, DHA su
pplementation resulted in decreases in 22:4n-6 (-30% in the 800-mg DHA grou
p only) and total n-6 (-6 and -12% in the 400- and 800-mg DHA groups, respe
ctively) fatty acids. Increases were noted in DHA (71 and 131% in the 400-
and 800-mg DHA groups, respectively), total n-3 fatty acids (42 and 67% in
the 400- and 800-mg DHA groups, respectively), and the n-3/n-6 ratio (50 an
d 93% in the 400- and 800-mg DHA groups, respectively). In seminal plasma,
DHA supplementation resulted in a decrease in 22:4n-6 (-31% in the 800-mg D
HA group only) and an increase in the ratio of n-3 to n-6 (35 and 33% in th
e 400- and 800-mg DHA groups, respectively). There were insignificant incre
ases in DHA and total n-3 fatty acids. In sperm, decreases were noted in 22
:4n-6 (-37 and -31% in the 400- and 800-mg DHA groups, respectively). There
were no other changes. There was no effect of DHA supplementation on sperm
motility. The results show that dietary DHA supplementation results in inc
reased serum-and possibly seminal plasma-phospholipid DHA levels, without a
ffecting the incorporation of DHA into the spermatozoa phospholipid in asth
enozoospermic men. This inability of DHA to be incorporated into sperm phos
pholipid is most likely responsible for the observed lack of effect of DHA
supplementation on sperm motility.